Cardiac Rhythm Management Devices | Market Insights | US | 2022
The COVID-19 global pandemic will have a significant impact on the US CRM device market in the short term, resulting in lost procedure volumes; however, following a period of recovery, the market will grow slightly through 2030. Revenue growth will be driven by rising ICM and pulse generator envelope procedure volumes and the adoption of premium-priced innovative products, such as leadless pacemakers and S-ICDs, but largely offset by flat pulse generator sales and price erosion.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the US cardiac rhythm management device market across an 11-year period.